Medical breakthroughs often emerge from years of careful research, but sometimes they arise from treatments never intended to solve the problem they ultimately transform. One of the most remarkable examples occurred in 2007, when a patient undergoing a high-risk procedure for blood cancer unexpectedly became the first person widely recognized as achieving long-term HIV remission after treatment. The case changed how scientists viewed the possibility of overcoming one of the world's most challenging viral infections and launched a new era of HIV cure research.
The patient, later known globally as the "Berlin Patient" was living with both human immunodeficiency virus (HIV) and acute myeloid leukemia (AML), an aggressive cancer affecting blood-forming cells. At the time, HIV was effectively controlled using antiretroviral therapy, but there was no known cure. Meanwhile, leukemia required immediate treatment, and conventional therapies were no longer sufficient.
